GRAIL Inc.
NASDAQ: GRAL0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Robert Ragusa
- Employees
- 910
- Headquarters
- Menlo Park, United States
- IPO year
- 2024
- Market cap
- $2.8B
- Website
- http://www.grail.com
Loading GRAL…
Loading profile data…Frequently asked questions about GRAL
What does GRAIL Inc. (GRAL) do?
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical...
Where does GRAL trade?
GRAIL Inc. (GRAL) trades on the NASDAQ.
What sector is GRAL in?
GRAIL Inc. (GRAL) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of GRAIL Inc.?
Robert Ragusa is the chief executive officer of GRAIL Inc. (GRAL).
Where is GRAIL Inc. headquartered?
GRAIL Inc. is headquartered in United States.
Does GRAL pay a dividend?
GRAIL Inc. (GRAL) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did GRAL go public?
GRAIL Inc. (GRAL) completed its initial public offering in 2024.